Artritis reumatoide como expresión del síndrome post COVID-19 en adultos mayores
Keywords:
Adulto mayor, Anciano, Artritis reumatoide, COVID-19, Enfermedad reumática, Sistema InmuneAbstract
La COVID-19 es una enfermedad viral que se caracteriza por afectar el sistema inmune condicionando un proceso inflamatorio local y sistémico que unido a los trastornos de la microcirculación constituyen los mecanismos etiopatogénicos de la enfermedad. La infección en adultos mayores tiene como riesgo aumentado los cambios que sobre el sistema inmune genera el proceso de envejecimiento. El objetivo de esta investigación es exponer los mecanismos que pueden justificar el aumento de la incidencia de enfermedades reumáticas, específicamente la artritis reumatoide, en adultos mayores previamente afectados por la COVID-19. Se identifica que las enfermedades reumáticas y la COVID-19 compartes similitudes relacionadas con la estimulación de los linfocitos T que constituyen la piedra angular del funcionamiento del sistema inmune. Los linfocitos T estimulados activan la cadena de sucesos que predisponen la aparición de enfermedades reumáticas como es el caso de la artritis reumatoide en pacientes adultos mayores con antecedentes de COVID-19.
Downloads
References
- Solis Cartas U, Martínez Larrarte JP. (2020). Therapeutic options to cytokine release syndrome in patients with COVID-19. Revista Cubana de Medicina Militar [Internet]. 2021[citado 2023 Jun 20];49(3), e783. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572020000300022&lng=es&tlng=en
- González Costa M, Padrón González AA. Factores etiopatogénicos de las enfermedades autoinmunes en el siglo XXI. Rev Cubana Invest Bioméd [Internet]. 2021[citado 2023 Jun 22];40(1): e842. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002021000100019&lng=es
- Arenas Soto CM, Diaz Mestre MP. Efluvio telógeno: una manifestación del síndrome post-COVID-19. Piel [Internet]. 2022 [citado 2023 Jun 18];37(2):S7–S9. Disponible en: https://doi.org/10.1016/j.piel.2021.06.013
- Solis Cartas U, Martinez Larrarte JP. Therapeutic options to cytokine release syndrome in patients with COVID-19. Rev Cub Med Mil [Internet]. 2020 [citado 2023 Jun 21];49(3): e783. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572020000300022&lng=es
- Boix V, Merino E. Post-COVID syndrome. The never ending challenge. Síndrome post-COVID. El desafío continúa. Medicina clínica [Internet]. 2022 [citado 2023 Jun 21];158(4):178–80. Disponible en: https://doi.org/10.1016/j.medcli.2021.10.002
- Cascella M, Rajnik M, Aleem A, Scott D, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. [Internet]. 2022[citado 2023 Jun 20];20(2). Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK554776/
- Chia Proenza D, Gómez Conde SY, del Toro Ravelo LM. Acercamiento a la COVID-19 desde una perspectiva pediátrica. Revista Cubana de Reumatología [Internet]. 2020[citado 2023 Jun 17];22(2). Disponible en: http://scielo.sld.cu/scielo.php?pid=S1817-59962020000200015&script=sci_arttext&tlng=pt
- Blanco-Melo D, Nilsson-Payant B, Wen-Chun L, Jean L, Albrecht R, tenOever B, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell [Internet]. 2020[citado 2023 Jun 19];181(5):1036-45. Disponible en: https://doi.org/10.1016/j.cell.2020.04.026
- Hoffmann M, Kleine-Weber H, Schroeder S, Müller M, Drosten C, Pöhlmann S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell [Internet]. 2021[citado 2023 Jun 20];181(2):271-80. Disponible en: https://dx.doi.org/10.1016%2Fj.cell.2020.02.052
- Solis Cartas U, Valdés González JL, Hernandez W, Martinez Larrarte JP. Manifestaciones reumáticas y dermatológicas en pacientes paucisintomáticos de COVID-19. Rev Cubana de Reumatolo [Internet]. 2020[citado 2023 Jun 21];22(4). Disponible en: https://www.globalrheumpanlar.org/manuscrito-articulo-original/manifestaciones-reumaticas-y-dermatologicas-en-pacientes?language=en&page=5&title
- Valdés JL, Valdés EM, Solis U. Dengue, COVID-19 y gota, una asociación infrecuente. Rev Cub de Reumatolo. [Internet]. 2020[citado 2023 Jun 23];22(Suppl: 1). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=102685
- Villafuerte Morales JE, Hernández Batista SDLC, Chimbolema Mullo SO, Pilamunga Lema CL. Manifestaciones cardiovasculares en pacientes con enfermedades reumáticas y COVID-19. Revista Cubana de Reumatología, [Internet]. 2021[citado 2023 Jun 18];23(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1817-59962021000100004
- CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021. MMWR. Morbidity and mortality weekly report[Internet]. 2021[citado 2023 Jun 21];70(21):792–3. Disponible en: https://doi.org/10.15585/mmwr.mm7021e3
- CDC COVID-19 Response Team. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020. MMWR. Morbidity and mortality weekly report, [Internet]. 2020[citado 2023 Jun 20];69(15):477–81. Disponible en: https://doi.org/10.15585/mmwr.mm6915e6
- Moriarty LF, Plucinski MM, Marston BJ, Kurbatova EV, Knust B, Murray EL, et al. Public Health Responses to COVID-19 Outbreaks on Cruise Ships - Worldwide, February-March 2020. MMWR. Morbidity and mortality weekly report [Internet]. 2020[citado 2023 Jun 22]; 69(12):347–52. Disponible en: https://doi.org/10.15585/mmwr.mm6912e3
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
